Investors / filer profile

Enright Patrick G

active in 4 companies · 2 of 3 positions beat the S&P ~6mo later

Pro
Bought: Pro
Sold: 18
Filings: 4
Companies: 2026-08-31
Last filed

EDGAR · CIK 0001253886 ↗

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+112.6%

median move per position

+9.5%

S&P 500 median, same spans

2 of 3

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$26.05M bought

All filings on record

Every Form 4 transaction we track for this filer


JAZZJazz Pharmaceuticals plc	Tax $408.4K · 1,692 sh	2026-08-31	—
JAZZJazz Pharmaceuticals plc	Tax $3.4K · 14 sh	2026-08-31	—
JAZZJazz Pharmaceuticals plc	Grant — · 1,605 sh	2026-08-05	—
MANEVeradermics, Inc	Buy $15.00M · 882,353 sh	2026-02-05	—
MANEVeradermics, Inc	Buy $3.27M · 192,647 sh	2026-02-05	—
MANEVeradermics, Inc	Convert — · 1,171,121 sh	2026-02-05	—
MANEVeradermics, Inc	Convert — · 1,171,121 sh	2026-02-05	—
MANEVeradermics, Inc	Convert — · 1,236,631 sh	2026-02-05	—
VERAVera Therapeutics, Inc.	Buy $250.0K · 5,882 sh	2025-12-11	—
ZBIOZenas BioPharma, Inc.	Buy $250.0K · 11,990 sh	2025-10-09	—

JAZZTax

2026-08-31 · Jazz Pharmaceuticals plc

$408.4K

—

JAZZTax

2026-08-31 · Jazz Pharmaceuticals plc

$3.4K

—

JAZZGrant

2026-08-05 · Jazz Pharmaceuticals plc

1,605

—

MANEBuy

2026-02-05 · Veradermics, Inc

$15.00M

—

MANEBuy

2026-02-05 · Veradermics, Inc

$3.27M

—

MANEConvert

2026-02-05 · Veradermics, Inc

1,171,121

—

MANEConvert

2026-02-05 · Veradermics, Inc

1,171,121

—

MANEConvert

2026-02-05 · Veradermics, Inc

1,236,631

—

VERABuy

2025-12-11 · Vera Therapeutics, Inc.

$250.0K

—

ZBIOBuy

2025-10-09 · Zenas BioPharma, Inc.

$250.0K

—

Newest 10 of 18 filingsEvery Form 4 on record, with outcomesPro →

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.